- Home
- ZYXI vs SRZN Comparison
ZYXI vs SRZN Comparison
Compare ZYXI & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYXI
- SRZN
- Stock Information
- Founded
- ZYXI 1996
- SRZN 2015
- Country
- ZYXI United States
- SRZN United States
- Employees
- ZYXI N/A
- SRZN N/A
- Industry
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- ZYXI Health Care
- SRZN Health Care
- Exchange
- ZYXI Nasdaq
- SRZN Nasdaq
- Market Cap
- ZYXI 72.3M
- SRZN 72.8M
- IPO Year
- ZYXI N/A
- SRZN N/A
- Fundamental
- Price
- ZYXI $2.26
- SRZN $9.39
- Analyst Decision
- ZYXI Buy
- SRZN Strong Buy
- Analyst Count
- ZYXI 3
- SRZN 2
- Target Price
- ZYXI $5.50
- SRZN $38.50
- AVG Volume (30 Days)
- ZYXI 132.8K
- SRZN 9.4K
- Earning Date
- ZYXI 07-31-2025
- SRZN 08-11-2025
- Dividend Yield
- ZYXI N/A
- SRZN N/A
- EPS Growth
- ZYXI N/A
- SRZN N/A
- EPS
- ZYXI N/A
- SRZN N/A
- Revenue
- ZYXI $172,401,000.00
- SRZN $11,638,000.00
- Revenue This Year
- ZYXI N/A
- SRZN N/A
- Revenue Next Year
- ZYXI $19.55
- SRZN N/A
- P/E Ratio
- ZYXI N/A
- SRZN N/A
- Revenue Growth
- ZYXI N/A
- SRZN N/A
- 52 Week Low
- ZYXI $1.66
- SRZN $5.90
- 52 Week High
- ZYXI $9.42
- SRZN $27.75
- Technical
- Relative Strength Index (RSI)
- ZYXI 49.49
- SRZN 62.73
- Support Level
- ZYXI $2.46
- SRZN $8.71
- Resistance Level
- ZYXI $2.60
- SRZN $9.50
- Average True Range (ATR)
- ZYXI 0.15
- SRZN 0.46
- MACD
- ZYXI 0.01
- SRZN 0.10
- Stochastic Oscillator
- ZYXI 46.75
- SRZN 91.30
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).